Trying to separate three different claims about hexarelin: that it is the right molecule, that it is the right dose, and that it does something useful.
I have started logging dose, time, and sleep because otherwise the anecdote is just a mood.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
Timing around sleep matters more than absolute dose with this class.
Curious whether the popular dose has any basis or is just the convenient one.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Most of what is called evidence here is one person, one vial, one month.
Test one thing at a time. It feels slower and it is the only way to learn anything. Same for me with hexarelin, unfortunately.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Baseline first.
Baseline first.
I would take the narrow conclusion. Broad ones are more interesting and less true.
Narrow conclusion.
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison. Not on hexarelin but the pattern is familiar.